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FKBP12.6 Deficiency and Defective Calcium Release
Channel (Ryanodine Receptor) Function Linked to
Exercise-Induced Sudden Cardiac Death
Introduction
Ventricular arrhythmias in the heart can be rapidly fatal,
a phenomenon referred to as sudden cardiac death.
Sudden cardiac death is associated with common car-
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cardiomyocytes that occur after repolarization of a car-University of Maryland Biotechnology Institute
diac action potential. The molecular basis for abnormalDepartment of Physiology
SR Ca2 release that causes DADs has not been fullySchool of Medicine
elucidated. DADs are, however, known to be blockedUniversity of Maryland
by ryanodine, providing evidence that RyR2 may play aBaltimore, Maryland 21201
key role in the pathogenesis of this aberrant Ca2 release4 Molecular Cardiology
(Marban et al., 1986; Song and Belardinelli, 1994).IRCCS Fondazione S. Maugeri
Catecholaminergic polymorphic ventricular tachycar-University of Pavia
dia (CPVT) is an arrhythmogenic disorder of the heartVia Ferrata 8
characterized by stress-induced bidirectional or poly-27100 Pavia
morphic ventricular tachycardia that leads to suddenItaly
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individuals present during childhood or adolescence
with repetitive exercise-induced syncopal events withArrhythmias, a common cause of sudden cardiac
30%–50% mortality by age 30 (Fisher et al., 1999; Swandeath, can occur in structurally normal hearts, al-
et al., 1999). Linkage studies and direct sequencing havethough the mechanism is not known. In cardiac mus-
identified mutations in the human cardiac ryanodine re-cle, the ryanodine receptor (RyR2) on the sarcoplasmic
ceptor gene (hRyR2) on chromosome 1q42-q43 in indi-reticulum releases the calcium required for muscle
viduals with CPVT (Laitinen et al., 2001; Priori et al.,contraction. The FK506 binding protein (FKBP12.6)
2001; Swan et al., 1999). Importantly, individuals withstabilizes RyR2, preventing aberrant activation of the
CPVT have ventricular arrhythmias when subjected tochannel during the resting phase of the cardiac cycle.
exercise testing, but they do not have these arrhythmiasWe show that during exercise, RyR2 phosphorylation
at rest.by cAMP-dependent protein kinase A (PKA) partially
RyR2 is the major Ca2 release channel required fordissociates FKBP12.6 from the channel, increasing
excitation-contraction coupling in cardiac muscle. Dur-intracellular Ca2 release and cardiac contractility.
ing excitation-contraction coupling, depolarization ofFKBP12.6/ mice consistently exhibited exercise-
the cardiac muscle cell membrane in phase zero of theinduced cardiac ventricular arrhythmias that cause
action potential (during the upstroke) activates voltage-sudden cardiac death. Mutations in RyR2 linked to
gated Ca2 channels. Ca2 influx through these channelsexercise-induced arrhythmias (in patients with cate-
in turn initiates Ca2 release via RyR2 from the sarco-cholaminergic polymorphic ventricular tachycardia
plasmic reticulum. This process is known as Ca2-[CPVT]) reduced the affinity of FKBP12.6 for RyR2 and
induced Ca2 release (Fabiato, 1983; Nabauer et al.,increased single-channel activity under conditions
1989). RyR2-mediated Ca2-induced Ca2 release acti-that simulate exercise. These data suggest that
vates the contractile proteins, which are responsible for“leaky” RyR2 channels can trigger fatal cardiac ar-
cardiac muscle contraction.
rhythmias, providing a possible explanation for CPVT.
During exercise, sympathetic nervous system stimula-
tion leads to catecholaminergic activation of -adrenergic
receptors (-AR) in the heart. -ARs are coupled via*Correspondence: arm42@columbia.edu
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Figure 1. Generation of FKBP12.6/ Mice
(A) The mouse FKBP12.6 gene (top), targeting
vector (middle), and homologous recombi-
nant mutant allele (bottom). A 3.5 kb Spe I-
Sac I segment that includes exons 3 and 4
was replaced with a neomycin-resistance
(neo) expression cassette.
(B) Southern blot analyses of FKBP12.6 het-
erozygous (/) or homozygous (/) and
wild-type mouse (/).
(C) FKBP12/12.6 immunoblot of heart homoge-
nate from FKBP12.6/ and FKBP12.6/ mice.
increases intracellular cAMP concentration that in turn with the clinical phenotype as individuals with these
mutant RyR2 only have arrhythmias when they exercise.activates cAMP-dependent protein kinase A (PKA). PKA
phosphorylation of RyR2 causes the release of the Together, these studies provide a link between altered
RyR2 channel function and ventricular arrhythmias andFK506 binding protein (FKBP12.6) from the channel
complex. RyR2 is a tetrameric channel, and each RyR2 suggest that defective RyR2 channel function due to
depletion of FKBP12.6 from the channel macromolecu-monomer binds one FKBP12.6. Phosphorylation of
RyR2 (Valdivia et al., 1995) and depletion of FKBP12.6 lar complex may be one molecular mechanism underly-
ing the aberrant SR Ca2 release that can cause DADsfrom the RyR2 macromolecular complex result in an
increase in RyR2 channel open probability (Marx et al., and triggered ventricular arrhythmias.
2000).
In the present study, we show that FKBP12.6-deficient Results
(FKBP12.6/) mice consistently exhibited exercise-
induced ventricular arrhythmias that are similar to those Exercise-Induced Arrhythmias in FKBP12.6/ Mice
observed in CPVT patients. Moreover, termination of FKBP12.6/ mice were generated by homologous re-
SR Ca2 release was defective in cardiomyocytes from combination, resulting in the absence of FKBP12.6 pro-
FKBP12.6/ mice (Xin et al., 2002), and cardiomyocytes tein in the heart (Figure 1). The hearts of male and female
from FKBP12.6/ mice exhibited DADs following cate- FKBP12.6/ mice were structurally normal based on
cholamine application that can trigger extrasystoles and echocardiography and histology (including absence of
cardiac arrhythmias. RyR2 channels from FKBP12.6/ fibrosis, see Supplemental Figure S1 online at http://
mice exhibited increased open probability during exer- www.cell.com/cgi/content/full/113/7/829/DC1). Exami-
cise compared to channels from FKBP12.6/ mice. nation of ECG parameters of conscious FKBP12.6/
We also report the biophysical properties of three and FKBP12.6/ mice revealed no significant differ-
distinct RyR2 mutations linked to CPVT in individuals ences in RR (/, 97.3  5 ms; /, 92.1  4 ms), PR
who manifest exercise-induced ventricular arrhythmias (/, 36.2  2.1 ms; /, 35.4  2.0 ms), QRS (/,
and have clinical features consistent with triggered ar- 17.4  1.8 ms; /, 16.4  1.4 ms), or rate corrected
rhythmias known to be associated with DADs. All three QT intervals (QTc; /, 56.7  3.0 ms; /, 55.1  4.0
mutant RyR2s exhibited reduced affinity for FKBP12.6 ms; n 10 [/] and n 6 [/], not significant). Thus,
and increased open probability compared to wild-type FKBP12.6/ mice show no structural cardiac abnormali-
(wt) channels. Importantly, the increased channel activ- ties and no ECG abnormalities or arrhythmias at rest
ity compared to wt was only observed after PKA phos- (Figures 2A and 2B).
phorylation of the channels (conditions that mimic the To test for cardiac arrhythmias, FKBP12.6/ and
FKBP12.6/ mice were subjected to an exercise proto-effect of exercise on the channel). This is in agreement
RyR2 Mutations Linked to Sudden Death
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Figure 2. Exercise-Induced Fatal Ventricular
Arrhythmias and DADs in FKBP12.6/ Mice
(A and B) There were no significant ECG abnor-
malities comparing conscious FKBP12.6/
mice to FKBP12.6/ mice.
(C) ECG following exercise and epinephrine.
Following strenuous exercise and injection
with epinephrine (8 min before the trace),
FKBP12.6/ mouse displayed polymorphic
ventricular tachycardia followed by death 4 min
following this trace. This stress test resulted in
ventricular arrhythmias in 8/8 (100%) of male
(n  3) and female (n  5) FKBP12.6/ mice,
compared to 0/6 (0%) of the FKBP12.6/
mice.
(D and E) Action potentials were recorded in
(D) FKBP12.6/ (n 19) and (E) FKBP12.6/
(n 38) cardiomyocytes during rapid pacing.
Action potentials were produced in patch-
clamped single cardiomyocytes stimulated
by brief current injections at 12 Hz in current
clamp mode. Upward arrows at the bottom of
(D) and (E) indicate the timing of the induced
action potentials. After depolarizations, as
the one shown in (E), were observed in
FKBP12.6/ cardiomyocytes (n  6) from
four FKBP12.6/ mice. The downward arrow
shows a DAD that produced an extrasystole
in a FKBP12.6/ cardiomyocyte.
col that has been used previously (Mohler et al., 2003). genetic backgrounds, 129SvEv versus DBA in the pres-
ent study).While no FKBP12.6/ mice (0 of 10) displayed arrhyth-
mias or syncopic events during the protocol, two of
eight FKBP12.6/ mice became unresponsive for 2–5 s Delayed after Depolarizations in FKBP12.6/
Cardiomyocytesafter strenuous exercise, and all of the FKBP12.6/ mice
(8/8) died following exercise plus epinephrine injection. To determine whether or not FKBP12.6 deficiency is
associated with increased risk of delayed after depolar-Following exercise, when epinephrine was adminis-
tered, no wt mice had arrhythmias with this stress proto- izations (DADs) that can trigger arrhythmias, we exam-
ined cardiomyocytes isolated from FKBP12.6/ and con-col, whereas 100% (8/8) of the FKBP12.6/ mice had
fatal arrhythmias consisting of a progression from a si- trol FKBP12.6/ mice with patch clamp. There were no
significant changes of the single-cell action potential (AP)nus rhythm (heart rate700–850 bpm) with episodes of
polymorphic ventricular arrhythmias (heart rate 1200 in myocytes from the hearts of both genotypes. However,
after depolarizations were observed in FKBP12.6/bpm) to sustained ventricular arrhythmias (Figure 2C).
Before death, two of the mice displayed significant pro- cardiomyocytes from four FKBP12.6/ mice examined
under conditions that simulate exercise (i.e., followinglonged polymorphic arrhythmias (6 s), four displayed
multiple short (0.5–2 s) runs of ventricular arrhythmia, the application of isoproterenol [1 M] or epinephrine
[1 M], and stimulation with action potentials at 12 Hzand two mice died without ECG monitoring. A previous
report using a different FKBP12.6/ mouse model to correspond to the heart rate of 700–750 bpm, at
which fatal exercise-induced cardiac arrhythmias oc-showed that male mice had a cardiomyopathy, and in
agreement with our findings, no cardiac arrhythmias curred in FKBP12.6/ mice) (Figures 2D–2E). Since both
FKBP12.6/ and FKBP12.6/ hearts were subjectedwere observed in nonexercised animals (Xin et al., 2002).
The effects of exercise were not reported. Moreover, to increased SERCA2 activity (due to PKA-dependent
phosphorylation of phospholamban, data not shown)male mice in the Xin et al. (2002) study had significant
hypertension that likely contributed to cardiac hypertro- and increased L type Ca2 channel activity (due to PKA-
dependent phosphorylation), and both genotypes werephy. There was no evidence of hypertension or cardiac
hypertrophy in our FKBP12.6/ mice, nor any differ- subjected to RyR2 phosphorylation by PKA, the re-
maining difference was the absence of FKBP12.6 in theences between males and females (differences between
the Xin et al. mice and ours could be due to distinct FKBP12.6/ mouse heart cells.
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Figure 3. Exercise-Induced Increased Open Probability of RyR2 from FKBP12.6/ Mice
(A) PKA phosphorylation of RyR2 from FKBP12.6/ and FKBP12.6/ mice was increased during exercise. Mice were exercised as described
in Experimental Procedures; at the termination of exercise, the heart was rapidly removed and flash frozen. RyR2 was immunoprecipitated
from cardiac homogenates and PKA phosphorylation of RyR2 was assessed using a phosphoepitope-specific antibody (anti-RyR2-P2809)
that specifically recognizes RyR2 PKA phosphorylated at RyR2-Ser2809. Immunoblots of RyR2 with anti-RyR2-5029 (Jayaraman et al., 1992),
an antibody that recognizes the carboxy terminus of RyR2, were used to show that equal amounts of RyR2 protein were in each sample.
(B) FKBP12.6 bound to RyR2 after exercise was decreased (due to PKA phosphorylation of RyR2, which dissociates FKBP12.6 from the
channel) in FKBP12.6/ mice. No FKBP12.6 was detected in the RyR2 macromolecular complex in FKBP12.6/ mice.
(C–F) Single-channel studies showing increased open probability of RyR2 from FKBP12.6/ mice compared to FKBP12.6/ after exercise.
Channel openings are upward, the dash indicates the level of full openings (4 pA), and the letter “c” indicates the closed state. Channels are
shown at compressed (5 s, upper tracing) and expanded (500 ms, lower tracing) time scales, and recordings are at 0mV. Amplitude histograms
of FKBP12.6/ and FKBP12.6/ channels revealed increased activity and subconductance openings in resting (see [E] tracing and insert in
amplitude histogram) and exercised FKBP12.6/ channels.
(G) Open probabilities (Po) of control and exercised FKBP12.6/ and FKBP12.6/ mice, revealing increased Po in FKBP12.6/ channels after
exercise (please note interruption in y axis) under conditions (low cytosolic [Ca2]  150 nM) that simulate diastole (the resting phase) in the
heart. Numbers above each bar indicate how many single channels were measured.
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RyR2 Channels from FKBP12.6/ Mice Exhibit at a low cis (cytosolic) [Ca2] of 150 nM to approximate
the conditions of cardiac muscle during diastole whenDefective Gating during Exercise
the heart is relaxed, and RyR2 channels have very lowNative RyR2 are tetramers comprised of four RyR2
open probability. In the absence of PKA phosphoryla-monomers, each of which binds a single FKBP12.6 mol-
tion, wt and all three mutant RyR2 had extremely lowecule. FKBP12.6 stabilizes the RyR2 channel in the
activity (see upper tracings in Figure 4B). There were noclosed state and reduces its activity (Brillantes et al.,
differences in single-channel properties of wt-RyR2 and1994; Kaftan et al., 1996). Stimulation of the sympathetic
mutant RyR2 examined over a wide range of cis (cyto-nervous system during exercise causes the release of
solic) [Ca2] from 50 nM to 5 mM (Figure 4B, top rightcatecholamines that activate -AR, which raises cAMP
graph).levels and activates protein kinase A in cardiac muscle.
The findings—that under basal conditions all threePKA phosphorylation of serine 2809 on RyR2 (RyR2-
CPVT-associated mutant RyR2 exhibited normal single-Ser2809) dissociates FKBP12.6 from the channel complex
channel properties, indistinguishable from those of(Marx et al., 2000) and increases the sensitivity of
RyR2-wt channels—were not surprising, given that pa-RyR2 to be activated by transient increases in [Ca2]i
tients with CPVT do not have arrhythmias at rest (Leen-(Valdivia et al., 1995). Therefore, PKA phosphorylation-
hardt et al., 1995; Priori et al., 2002). However, patientsinduced dissociation of FKBP12.6 from RyR2 and the
with CPVT have exercise-induced arrhythmias (Leen-increased sensitivity of RyR2 to [Ca2]i (see below) are
hardt et al., 1995; Priori et al., 2002). To approximatephysiological mechanisms involved in upregulating
the effects of exercise, which activates PKA throughRyR2 activity (Marx et al., 2000), which increase SR Ca2
-AR signaling pathways in cardiomyocytes, we com-release. This occurs as part of a signaling system (the
pared the single-channel properties of PKA phosphory-“fight-or-flight” stress response) that increases cardiac
lated wt and mutant RyR2 channels in planar lipid bi-output to meet the metabolic demands of exercise.
layers.To determine the effects of exercise on RyR2,
PKA phosphorylation significantly increased the activ-PKA phosphorylation of the channel was examined in
ities (open probability; Po) of the wt-RyR2 and CPVTFKBP12.6/ and FKBP12.6/ mice after exercise. We
mutant channels (bottom tracings in Figure 4B). Thefound that during exercise, RyR2s are PKA phosphory-
open probabilities of the mutant RyR2 (RyR2-S2246L,lated (Figure 3A) and, in the case of the FKBP12.6/
RyR2-R2474S, RyR2-R4497C) were, however, signifi-mice, partially depleted of FKBP12.6 (Figure 3B). RyR2s
cantly higher than those for wt-RyR2 channels (Figurefrom both FKBP12.6/ and FKBP12.6/ were PKA
4C, n  9, p  0.05). Similarly, gating frequencies werephosphorylated to a similar extent during exercise (Fig-
significantly higher in the mutant channels (n  9, p ure 3A). During exercise, the open probabilities (Po) of
0.05, data not shown). The increased open probabilitiesRyR2 channels were increased, compared to channels
and gating frequencies exhibited by the mutant chan-from nonexercised animals (Figures 3C–3F). However,
nels indicate that they are more sensitive to activationFKBP12.6/ RyR2 channels from exercised mice exhib-
by PKA. After PKA phosphorylation, both wt and CPVT-ited10 fold greater increase in open probability (com-
associated mutant RyR2 were more sensitive to Ca2-pare Figures 3D and 3F) compared to age- and sex-
induced activation at moderate [Ca2]i (Figure 4B, bot-matched FKBP12.6/ control animals subjected to the
tom right panel), and this effect was exaggerated in thesame degree of exercise (Figure 3G). These channels
mutant channels, suggesting that they are more activewere studied under conditions of low cis (cytosolic)
than the wt channels during exercise because they ex-[Ca2] of 150 nM to approximate the conditions in the
hibit increased Ca2-dependent activation at low [Ca2]i.heart during diastole when the RyR2 channel should
To determine the effects of the CPVT mutations onhave very low open probability to prevent diastolic SR
FKBP12.6 binding to RyR2, microsomes were preparedCa2 leak that can trigger cardiac arrhythmias. Thus,
from HEK293 cells expressing wt-RyR2 and three CVPT
the significant increase in RyR2 open probability under
mutations (RyR2-S2246L, RyR2-R2474S, and RyR2-
these conditions in the FKBP12.6/ channels suggests
R4497C). The amount of RyR2 in these microsomes was
that these channels could be leaky during diastole when determined by [3H] ryanodine binding. FKBP12.6 binding
the mice are exercised. curves were obtained by incubating the microsomes
with 35S-labeled FKBP12.6. The dissociation constants
Exercise-Induced Sudden Cardiac Death (Kd) for FKBP12.6 binding to the channels (n  3) was
Is Linked to Defective RyR2 Gating determined from Scatchard analyses (Figure 4D):
The clinical phenotype of CPVT consists of ventricular 108.3  9.1 nM for wt-RyR2, 182.7  8.1 nM for RyR2-
arrhythmias inducible with exercise stress testing. Dur- S2246L, 215.7  6.0 nM for RyR2-R2474S, and 202.2 
ing exercise, patients may display a typical progression 11.2 nM for RyR2-R4497C. The significant increase (p
from isolated premature ventricular contractions to poly- 0.001) in Kd indicates that the CVPT mutants have de-
morphic ventricular tachycardia that may degenerate creased affinity for FKBP12.6 compared to wt channels.
into ventricular fibrillation and cause sudden cardiac Because patients with CPVT are heterozygous for the
death (Leenhardt et al., 1995; Priori et al., 2002). mutant RyR2 allele, we also examined the function of
To determine whether the exercise-induced arrhyth- heterotetrameric channels by expressing equal amounts
mias in CPVT patients are associated with defects in of wt-RyR2 and CPVT mutant RyR2 in HEK293 cells.
SR Ca2 release channel function, we expressed three Because the precise composition of any given channel
mutant forms of RyR2 corresponding to known CPVT studied in a bilayer experiment cannot be determined,
missense mutations (RyR2-S2246L, RyR2-R2474S, and we pooled data from multiple heterotetrameric chan-
nels. As with the homotetrameric CPVT-associated mu-RyR2-R4497C) (Figure 4A). Experiments were performed
Cell
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Figure 4. RyR2 Mutations Linked to Exercise-Induced Sudden Cardiac Death Reduce FKBP12.6 Affinity and Increase RyR2 Activation by PKA
Phosphorylation.
(A) Location of CPVT-associated RyR2 mutations. CPVT mutations in RyR2 are indicated with thin vertical lines; the three CPVT mutations
studied in this paper are indicated with thick vertical lines. FKBP12.6, binding site in RyR2; S2809, PKA phosphorylation site on RyR2. Three
regions containing skeletal muscle RyR1 mutations linked to malignant hyperthermia (MH) and central core disease (CCD) are indicated with
RyR2 Mutations Linked to Sudden Death
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tant RyR2 channels, heterotetrameric RyR2 channels channel function. Taken together, these results suggest
that partial depletion of FKBP12.6 from the RyR2 macro-also exhibited the same altered single-channel proper-
ties, including an increase in open probability after PKA molecular complex, which occurs physiologically during
exercise, is associated with increased RyR2 open prob-phosphorylation (Figures 4E–4F). In addition, the affinity
of FKBP12.6 for the heterotetrameric RyR2-wt 	 RyR2- ability, but more severe deficiency of FKBP12.6 in the
RyR2 complex (such as in the FKBP12.6/ mouse orR2474S was also reduced (158.3  3.1 nM), compared
to RyR2-wt (108.3  9.1 nM for wt, p  0.01). Taken patients with the CPVT mutations) can result in channels
with significantly increased open probability during di-together, these data show that CPVT-associated mutant
RyR2 channels exhibit significantly altered single-chan- astole that is not observed with wild-type channels from
normal hearts.nel properties compared to wt-RyR2 channels, but only
after PKA phosphorylation.
Discussion
FKBP12.6 Restores Normal Gating to Defective
In the present study, we show that both RyR2 fromRyR2 Channels
FKBP12.6/ mice that exhibit exercise-induced suddenWe have previously shown that FKBP12.6 cannot bind
cardiac death and CPVT-associated mutant RyR2s thatto PKA phosphorylated RyR2 (Marx et al., 2001, 2000).
are linked to exercise-induced arrhythmias in patientsWe now show that FKBP12.6 also cannot bind to a
exhibit significantly increased open probabilities undermutant RyR2-S2809D that mimics constitutively PKA
conditions that correspond to diastole in the heart dur-phosphorylated RyR2 (Figure 5A). We wanted to deter-
ing exercise. These data suggest that in vivo, SR Ca2mine whether or not the defective gating in the mutant
leak through PKA phosphorylated, FKBP12.6-depletedCPVT-associated RyR2 was due to reduced FKBP12.6
RyR2 can occur. Indeed, DADs were observed inbinding. However, since wild-type FKBP12.6 cannot
cardiomyocytes from FKBP12.6/ mice during simu-bind to PKA phosphorylated RyR2, we generated a mu-
lated exercise. Importantly, RyR2 from FKBP12.6/tant form of FKBP12.6 with serine residue 37 substituted
mice and CPVT-RyR2 exhibit normal channel functionfor aspartate acid (FKBP12.6-D37S) that is capable of
under basal conditions and only show defective functionbinding to PKA phosphorylated RyR2 or to the RyR2-
(i.e., increased open probability) when they are exam-S2809D mutant (Figure 5A). We chose to modify the
ined under conditions that correspond to exercise-negative charge on Asp37 because this residue is near
induced stimulation. The increased open probabilitiesthe hydrophobic binding pocket when FKBP12 is bound
of the channels from FKBP12.6/ mice during exerciseto the TGF receptor I (Huse et al., 1999) and might be
and the CPVT-associated mutant RyR2, combined withinvolved in PKA phosphorylation-induced dissociation
DADs observed in cardiomyocytes from the FKBP12.6/of FKBP12 or FKBP12.6 from RyR1 or RyR2, respectively,
mice, suggest that SR Ca2 leak via RyR2 can initiatewhen an additional negative charge is added to the chan-
DAD-triggered arrhythmias (Figure 6).nel after phosphorylation. Indeed, addition of the mutant
FKBP12.6-D37S restored normal (low activity) channel
function to RyR2-S2809D channels (Figure 5B). FKBP12.6 Deficiency Causes Exercise-Induced
Sudden Cardiac DeathMoreover, in contrast to wild-type FKBP12.6, FKBP12.6-
D37S was capable of binding to RyR2 channels isolated Cardiac ventricular arrhythmias are a major cause of
mortality, but the molecular basis for the triggers thatfrom exercised FKBP12.6/ mouse hearts (Figure 5C)
and restored normal channel function (Figure 5D). Fi- initiate arrhythmias is not well understood. In the present
study, we have found that RyR2 channels from exercisednally, FKBP12.6-D37S, but not wild-type FKBP12.6, also
bound to PKA-phosphorylated CPVT-associated RyR2 FKBP12.6/ mice display dramatically increased open
probabilities that were not observed in exercisedmutant channels (Figure 5E) and restored normal chan-
nel function (Figure 5F). Thus, we have generated a mu- FKBP12.6/ mice. These data suggest that the re-
maining FKBP12.6 in the RyR2 channel complexes fromtant form of FKBP12.6 that, unlike wild-type FKBP12.6,
binds to PKA phosphorylated RyR2 and restores normal exercised FKBP12.6/ mice (Figure 5B) suffice to keep
thick gray lines. CPVT and MH/CCD mutations occur in highly homologous regions of RyR2 and RyR1, respectively, suggesting that common
defects in SR Ca2 release may play a role in these disorders.
(B) CPVT mutant RyR2 channels exhibit altered channel activity only under conditions that simulate exercise. Single-channel recordings of
wt and CPVT mutant RyR2 expressed in HEK293 cells treated with PKA plus the PKA inhibitor PKI5-24. RyR2-wt and CPVT-associated mutant
channels exhibit low activity under basal conditions with cis (cytosolic) [Ca2] of 150 nM. PKA phosphorylated CPVT mutant RyR2 exhibit
increased activity compared to RyR2-wt channels. A minimum of 8–12 channels from at least two separate preparations were recorded for
the RyR2-wt and each mutant RyR2 channel for each condition shown. Right-hand panels show normalized Po plotted as a function of
cytosolic [Ca2].
(C) Po of RyR2-wt and CPVT-associated mutant RyR2 channels after PKA phosphorylation; the asterisk indicates p  0.05; numbers above
each bar indicate how many single channels were measured.
(D) 35S-labeled FKBP12.6 binding to microsomes containing RyR2-wt and CPVT-associated mutant RyR2 channels, indicating decreased
FKBP12.6 affinity for the CPVT-associated mutant RyR2 channels.
(E) RyR2-wt and one of the CPVT-associated mutant RyR2 (RyR2-R2474S) were expressed as homo- or heterotetrameric channels. Representa-
tive single-channel traces of RyR2-wt, RyR2-R2474S, and heterotetrameric wt 	 R2474S channels are shown, revealing increased activity of
wt 	 R2474S channels after PKA phosphorylation.
(F) Average open probabilities for RyR2-wt, wt 	 R2474S, and RyR2-R2474S channels after PKA phosphorylation; asterisk indicates p  0.05.
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Figure 5. A Mutant FKBP12.6-D37S Restores Normal Single-Channel Function to Channels from Exercised FKBP12.6/ Mice and PKA-
Phosphorylated CPVT Mutant Channels
(A) Immunoblot showing equivalent amounts of RyR2 immunoprecipitated from murine cardiac SR (CSR) and recombinant RyR2-S2809D
expressed in HEK293 cells, using anti-RyR-5029 antibody that recognizes the carboxy terminus of RyR (Jayaraman et al., 1992). Immunoblot
of FKBP12.6 showing dissociation of FKBP12.6 from RyR2 following PKA phosphorylation. Wild-type FKBP12.6 (final concentration 250 nM)
does not bind to PKA phosphorylated RyR2. The mutant FKBP12.6-D37S (250 nM) binds to PKA phosphorylated RyR2 channels. RyR2-
S2809D mimics constitutively PKA-phosphorylated RyR2 channels and, therefore, does not bind FKBP12.6. However, mutant FKBP12.6-D37S
binds RyR2-S2809D channels.
(B) Single-channel tracings of RyR2-S2809D channels treated with FKBP12.6 (top; n  10) and mutant FKBP12.6-D37S (bottom; n  9),
showing increased open probability of RyR2-S2809D channels, similar to PKA-phosphorylated RyR2 channels (Marx et al., 2000). Binding of
FKBP12.6-D37S to RyR2-S2809D channels rescued normal channel gating and decreased open probability (bottom). Amplitude histograms
are shown on the right, revealing the presence of partial openings or subconductance states in the FKBP12.6-treated channels, but not in
the presence of FKBP12.6-D37S.
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PKA phosphorylated RyR2 channels closed during dias- upregulating RyR2 activity (Marx et al., 2000) to increase
SR Ca2 release in response to exercise or stress.tole. Previous studies examining the phenotype of an
independently generated FKBP12.6/ mouse reported
defects in cardiomyocyte Ca2 signaling, but exercise- CPVT RyR2 Mutations Linked to Exercise-Induced
induced arrhythmias were not studied (Xin et al., 2002). Sudden Cardiac Death
Our results indicate that the absence of FKBP12.6 in Although CPVT-associated RyR2 mutations exhibit re-
the RyR2 channel complex predisposes mice to DADs, duced binding of FKBP12.6 to RyR2, these mutant RyR2
ventricular arrhythmias, and sudden cardiac death dur- channels were able to bind FKBP12.6 under basal condi-
ing exercise and stimulation of the -AR pathway. tions. This finding is consistent with the fact that CPVT
We have previously shown that PKA phosphorylation patients do not exhibit arrhythmias under resting condi-
of RyR2 causes dissociation of FKBP12.6 from the chan- tions. Since PKA phosphorylation-induced dissociation
nel complex (Marx et al., 2000). In this study, we con- of FKBP12.6 is part of the mechanism by which RyR2
firmed this finding using a mutant channel, RyR2- channels are activated during exercise, the reduced af-
S2809D, that mimics constitutively PKA phosphorylated finity of FKBP12.6 likely plays a role in the increased
RyR2 and, therefore, cannot bind FKBP12.6 (Figures 5A sensitivity of mutant channels to activation by PKA. In-
and 5B). The finding that mutant FKBP12.6-D37S is able deed, following PKA phosphorylation, the CPVT-associ-
to bind PKA phosphorylated RyR2 or RyR2-S2809D is ated RyR2 mutations examined in this study resulted in
consistent with the model that charge repulsion second- channels that have increased activities compared to wt
ary to the addition of the negatively charged phosphate channels examined under the same conditions. Thus,
group to RyR2-S2809 causes dissociation of FKBP12.6 during exercise, PKA phosphorylation of CPVT mutant
from the channel complex. RyR2 increases the probability of after depolarizations
The finding that FKBP12.6-D37S could rescue the (low that can trigger arrhythmias (Figure 6).
activity) channel phenotype in RyR2 from exercised We found that under basal conditions, CPVT-associ-
FKBP12.6/ mice or CPVT mutant RyR2 channels ated RyR2 channels exhibited normal activity, in con-
strongly suggests that the absence of FKBP12.6 follow- trast to a previous report that the RyR2-R4497C mutant
ing PKA phosphorylation causes RyR2 channel hyperac- had increased basal activity at very low [Ca2] (Jiang et
tivity. The absence of FKBP12.6 may trigger arrhythmias al., 2002). We did not observe any difference in channel
in FKBP12.6/ mice and patients with CPVT-associated function even at a [Ca2] of 50 nM, which is below that of
mutations in RyR2. Moreover, our results suggest that resting cardiomyocytes or during diastole when cardiac
increasing FKBP12.6 binding to phosphorylated RyR2 muscle is relaxed. The fact that in the present study
channels may provide a novel and very specific thera- mutant RyR2 only exhibited defects after PKA phos-
peutic strategy to prevent triggered arrhythmias in CPVT phorylation, corresponding to the condition of the chan-
and heart failure. nels during exercise, supports the relevance of these
specific alterations in channel function to the exercise-
induced arrhythmias in CPVT patients. Moreover, it isPKA Phoshorylation of RyR2 Is Part of the
difficult to understand how any defect found in theFight-or-Flight Response
CPVT-associated RyR2 channels under nonexercisePKA phosphorylation of RyR2 occurs as part of an im-
conditions can be linked to SCD in these patients be-portant physiological stress pathway known as the fight-
cause they never have arrhythmias at rest.or-flight response (Marks, 2000). This signaling pathway
provides a mechanism whereby sympathetic nervous
system activation in response to exercise or stress re- Delayed after Depolarizations Associated with Leaky
Ryanodine Receptorssults in enhanced cardiac output required to meet the
metabolic demands of the relevant stress. Sympathetic DADs are oscillations in the plasma membrane potential
occurring after completion of the cardiac action poten-nervous system stimulation during exercise causes the
release of catecholamines that activate -AR, which tial that are caused by aberrant SR Ca2 release, re-
sulting in a Ca2-activated transient inward (depolariz-raises intracellular cAMP levels and, hence, activates
PKA in cardiac muscle. PKA phosphorylation of RyR2 at ing) current (Iti) (Fozzard, 1992; Wit and Rosen, 1983).
Previous pharmacological studies, showing that ryano-Ser2809 dissociates FKBP12.6 from the channel complex
and provides a physiological mechanism involved in dine specifically inhibits DADs, suggest that they may
(C) Immunoblots of RyR2 and FKBP12.6 of CSR from two exercised male (M) and two female (F) FKBP12.6/ mice. Whereas wild-type
FKBP12.6 does not, FKBP12.6-D37S does bind to RyR2 isolated from exercised FKBP12.6/ mouse hearts.
(D) Single-channel tracings of RyR2 channels isolated from exercised FKBP12.6/ hearts treated with wild-type FKBP12.6 (n  14), showing
high open probability and subconductance states (see histogram on the right). Binding of FKBP12.6-D37S completely rescued the channel
phenotype (n  9): open probability is dramatically decreased, and no subconductance openings were observed.
(E) Immunoblots of recombinant RyR2-R2474S expressed in HEK293 cells. FKBP12.6-D37S also binds to PKA-phosphorylated CPVT-associated
mutant RyR2-R2474S channels.
(F) Single-channel tracings of CPVT-associated mutant RyR2-R2474S channels after PKA phosphorylation and treatment with wild-type
FKBP12.6 (n 13), revealing high open probability and the presence of subconductance states (see amplitude histogram). Binding of FKBP12.6-
D37S completely normalized channel gating and open probability (n  11). For each tracing, channel openings are upward, the dash indicates
the level of full openings (4 pA), and the letter “c” indicates the closed state. Channels are shown at compressed (5 s, upper tracing) and
expanded (500 ms, lower tracing) time scales, and recordings are at 0mV.
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with CPVT during exercise testing occurred at a sinus
rate 100 beats per minute (107  7 beats per minute,
range 100–120, n  9). Ventricular tachycardia devel-
oped at a sinus rate 130 bpm (mean 148  22; range
135–204). Interestingly, the coupling interval of ventricu-
lar tachycardias (352  26 ms) was significantly shorter
than that of isolated premature beats (p  0.0001), indi-
cating that the rate dependency of arrhythmias in the
carriers of the three RyR2 mutations fulfills the criteria
for DAD-mediated triggered activity (Fozzard, 1992).
A Potential Molecular Mechanism for Triggered
Cardiac Arrhythmias
While CPVT is a rare inherited disorder, our data showing
that a defect in RyR2 function is linked to sudden cardiac
death may have broader implications. The elucidation
of the defect in CPVT-associated RyR2 provides a link
Figure 6. Model of Mechanism by Which SR Ca2 Leak May Initiate between the phenotype of leaky SR Ca2 release
Delayed after Depolarizations that Trigger Cardiac Arrhythmias channels and cardiac arrhythmias. A transient exercise-
During EC coupling in cardiac muscle RyR2 on the SR is activated induced defect in RyR2 function likely provides a mecha-
by the influx of Ca2 through the voltage-gated calcium channel nism for the exercise-induced arrhythmias in CPVT (Fig-
(VGCC) on the transverse tubule (T tubule). In response to stress/ ure 6).
exercise-induced activation of the sympathetic nervous system, RyR2
Heart failure, a leading cause of mortality in the devel-is PKA phosphorylated, which causes dissociation of FKBP12.6
oped world, is associated with altered RyR2 functionfrom the channel and increases its open probability. This is part of
due to PKA hyperphosphorylation and depletion ofa normal physiological stress response (e.g., fight or flight). In normal
hearts, the wild-type RyR2 is able to remain tightly shut, even when FKBP12.6 from the channel complex that may cause
it is physiologically PKA phosphorylated, during diastole when the aberrant SR Ca2 release (Marx et al., 2000). Indeed,
heart muscle is relaxed so that it can refill with blood in preparation RyR2 from failing hearts exhibits the same defective
for the next contraction (systole). This is necessary to prevent SR
single-channel properties as the RyR2 from FKBP12.6/Ca2 leak during diastole, which can initiate DADs that can trigger
mice and the CPVT-associated RyR2 examined undercardiac arrhythmias (Fozzard, 1992; Wit and Rosen, 1983). In the
exercise conditions (Marx et al., 2000). This is likelycase of the CPVT-associated RyR2 mutant channels, increased ac-
tivity (increased open probability) of the channels when they are because heart failure is a chronic hyperadrenergic state,
PKA phosphorylated (due to decreased binding affinity of FKBP12.6) resulting in chronic PKA hyperphosphorylation of RyR2
increases the probability of aberrant RyR2 opening during diastole, channels and depletion of FKBP12.6 from the RyR2
which can activate DADs due to inward depolarizing currents, possi-
macromolecular complex (Marx et al., 2000).bly through the sodium/calcium exchanger, which are triggers for
PKA phosphorylated CPVT-associated mutant RyR2cardiac arrhythmias (Pogwizd et al., 1998). Similar mechanisms may
and wild-type RyR2 channels from failing human heartsunderlie cardiac arrhythmias in heart failure in which structurally
normal RyR2 are PKA hyperphosphorylated, resulting in defective both exhibit increased activities at low cytosolic [Ca2],
channel function (Marx et al., 2000) that may promote SR Ca2 leak which may promote SR Ca2 leak. The distinction be-
that can trigger arrhythmias (Pogwizd et al., 2001). The likelihood tween these two disease states is that in CPVT, the
of cardiac arrhythmias triggered by activation of inward depolarizing
defective channel function is due to inherited mutationscurrents via the sodium/calcium exchanger is further enhanced in
in RyR2 that reduce the affinity for FKBP12.6 and impairheart failure due to upregulation of the exchanger (Pogwizd et al.,
the ability of the channel to close during diastole,2001).
whereas in heart failure, the RyR2 channel complexes
are depleted of FKBP12.6 due to chronic PKA hyper-
phosphorylation (Marx et al., 2000). Taken together,be due to defective SR Ca2 release and implicate RyR2
these data suggest that the mechanisms for triggeredin this process (Marban et al., 1986; Song and Belardi-
arrhythmias in heart failure patients may be similar tonelli, 1994). The present study strengthens this mecha-
those in CPVT and in the FKBP12.6/ mouse. It shouldnistic link between RyR2 and DADs in the setting of
be noted that cardiac arrhythmias in failing hearts aretriggered ventricular arrhythmias.
likely due to multiple causes and those triggered by SRDAD-induced triggered activity has been proposed as
Ca2 leak likely represent a subset of these arrhythmias.the principal mechanism for CPVT-associated exercise-
induced arrhythmias (Priori et al., 2002). The biophysical
Experimental Proceduresdefects in CPVT mutant channels were only observed
when the channels were subjected to PKA phosphoryla- FKBP12.6/ Mice
tion, which mimics the condition of the channels during Mouse genomic 
-phage clones for the murine ortholog of the hu-
man FK506 binding protein 12.6 (FKBP12.6) were isolated from aexercise. This provides further evidence supporting the
DBA/1lacJ library using a full-length murine cDNA probe in the labo-relevance of these defects in channel function to the
ratory of Dr. John McNeish at Pfizer, Inc. The targeting vector wasarrhythmias in patients, because the arrhythmias are
designed to delete exons 3 and 4, which contain the entire codingalso exclusively observed during stress and can be elic-
sequences for murine FKBP12.6 (Bennett et al., 1998) by replacing
ited with exercise testing. 3.5 kb of murine genomic DNA with a PGK-neo selectable marker.
In support of this mechanism, we found that the onset A 5.0 kb 5 fragment and a 1.9 kb 3 fragment were cloned into
pJNS2, a backbone vector with PGK-neo and PGK-TK cassettes.of premature ventricular contractions (PVCs) in patients
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The DBA/lacJ embryonic stem (ES) cells were grown and transfected Single-Channel Recordings
Single-channel recordings of native RyR2 from mouse hearts orusing established protocols. Targeted ES cells were first screened
by Southern analysis, and five positive ES cell lines were analyzed recombinant RyR2 were acquired under voltage-clamp conditions
at 0mV, as described (Marx et al., 2000). Symmetric solutions usedby PCR to confirm homologous recombination. Targeted ES cells
from cell line #97 were injected into C57Bl/6 blastocysts. Male chi- for channel recordings were trans compartment: 250 mM HEPES,
53 mM Ba(OH)2 (in some experiments, Ba[OH]2 was replaced bymeras were bred to DBA/1lacJ females and germline offspring iden-
tified by brown coat color. Germline offspring were genotyped using Ca[OH]2) (pH 7.35), and cis compartment: 250 mM HEPES, 125 mM
Tris-base, 1.0 mM EGTA, and 0.5 mM CaCl2 (pH 7.35). Unless other-5 Southern analysis. Positive FKBP12.6/ males and females were
intercrossed and offspring resulted in FKBP12.6/ mice at approxi- wise indicated, single-channels recordings were made in the pres-
ence of 150 nM [Ca2] and 1.0 mM [Mg2] in the cis compartment.mately 25% frequency. FKBP12.6/ mice were fertile. All studies
performed with FKBP12.6/ mice used age- and sex-matched Ryanodine (5 mM) was applied to the cis compartment to confirm
identity of all channels. Data were analyzed from digitized currentFKBP12.6/ mice as controls. No differences were observed be-
tween FKBP12.6/ mice raised on the following backgrounds: DBA/ recordings using Fetchan software (Axon Instruments, Union City,
CA). All data are expressed as mean SEM. The unpaired Student’sC57BL6 mixed, pure DBA, and pure C57BL6.
Southern blot analysis of DNA cut with Bgl II mice yielded an 8.5 t test was used for statistical comparison of mean values between
experiments. A value of p 0.05 was considered statistically signif-kb and 7.7 kb band for wild-type mice and homozygous mutants,
respectively. The absence of FKBP12.6 protein was demonstrated icant.
by immunoblotting in cardiac tissue (Figure 1C).
Cardiac samples from FKBP12.6/ and FKBP12.6/ mice were Action Potential Recordings
homogenized in 1.0 ml buffer (10 mM Tris maleate [pH 6.8], 20 mM Cardiomyocytes were isolated from FKBP12.6/ or FKBP12.6/
NaF, and protease inhibitors), centrifuged at 3000 	 g for 10 min, mouse hearts using the Langendorff method (Reiken et al., 2003)
supernatant at 12,000 	 g for 20 min, then 120,000 	 g for 30 min, and superfused with 140 mM NaCl, 5 mM KCl, 0.5 mM MgCl2, 2.5
resuspended in 50 l buffer (10 mM Tris maleate [pH 6.8], 0.9% mM CaCl2, 0.33 mM NaH2PO4, 5.5 mM glucose, 0.5 mM NaF, and
NaCl, and 300 mM sucrose), aliquoted, and stored at 80C. 5 mM HEPES (pH 7.40) at 35C–37C,  1 M isoproterenol or 1 M
epinephrine. Pipette (1–3 M) solution was 10 mM NaCl, 130 mM
KCl, 1.0 mM MgCl2, 5 mM MgATP, 10 mM HEPES, and 20 mM TEA-Telemetry Recording and Exercise Testing in Mice
Cl (pH 7.20 with KOH). Axopatch 200A was used in current clampFKBP12.6/ and FKBP12.6/ mice were maintained and studied
mode to record action potentials (Mohler et al., 2003). Current injec-according to protocols approved by the Institutional Animal Care
tions triggered action potentials at a constant rate 12 Hz.and Use Committee of Columbia University. Mice were anaesthe-
tized using an intraperitoneal injection of ketamine (50 g/kg) and
Acknowledgmentsxylazine (10 g/kg). ECG radiotelemetry recordings of ambulatory
animals were obtained48 hr following intraperitoneal implantation
This work was supported by grants to A.R.M. from the NIH, a Tele-(Data Sciences International, St. Paul, MN) (Mitchell et al., 1998).
thon grant (#0227/01) and a Leducq Foundation grant to S.G.P,Standard criteria were used to measure ECG parameters (Mitchell
grants from the NHLBI to W.J.L., and a grant from Deutscheet al., 1998). For stress tests, mice were exercised on an inclined
Forschungsgemeinschaft to S.E.L. A.R.M. is the Doris Duke Charita-treadmill until exhaustion, and then intraperitoneally injected with
ble Foundation Distinguished Clinical Scientist.epinephrine (0.1–0.5 mg/kg) (Mohler et al., 2003). Resting heart rates
of ambulatory animals were averaged over 4 hr.
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